SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-007864
Filing Date
2017-01-11
Accepted
2017-01-11 16:52:33
Documents
4
Period of Report
2017-01-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d280049d8k.htm 8-K 19622
2 EX-5.1 d280049dex51.htm EX-5.1 9532
3 EX-10.1 d280049dex101.htm EX-10.1 204279
4 GRAPHIC g280049ex5_1logo.jpg GRAPHIC 8374
  Complete submission text file 0001193125-17-007864.txt   246439
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 17523352
SIC: 2835 In Vitro & In Vivo Diagnostic Substances